DEA Seeks Feedback on Extending Form 250 for Drug Quotas
Published Date: 9/23/2026
Notice
Summary
The DEA is asking for your thoughts on keeping their form (DEA Form 250) that lets people apply for limits on certain controlled substances and chemicals for next year. This affects businesses and individuals who handle these substances, and the DEA wants to make sure the form is easy to use and not too time-consuming. You have until November 23, 2026, to share your feedback—no money changes, just a chance to help improve the process!
Analyzed Economic Effects
1 provisions identified: 0 benefits, 1 costs, 0 mixed.
Mandatory DEA Form 250 Quota Application
If you plan to use any Schedule I or II controlled substance, or the List I chemicals ephedrine, pseudoephedrine, or phenylpropanolamine, for manufacturing during the next calendar year, you must apply to the DEA using DEA Form 250 to obtain a procurement quota. The DEA estimates 262 registrants will participate, each response takes 30 minutes, the average registrant files about 10.8588 responses per year, and the total annual burden is 1,423 hours with an estimated $0 monetary cost. You can submit comments on this information collection through November 23, 2026.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Related Federal Register Documents
2026-16981, Application for Relief From Disabilities Imposed by Federal Laws With Respect to the Acquisition, Receipt, Transfer, Shipment, Transportation, or Possession of Firearms
The Department of Justice ("the Department") is implementing criteria to guide determinations for granting relief from disabilities imposed by federal laws with respect to the acquisition, receipt, transfer, shipment, transportation, or possession of firearms. The criteria are designed to ensure that the fundamental right of the people to keep and bear arms is not unduly infringed, that those people granted relief are not likely to act in a manner dangerous to public safety, and that granting such relief would not be contrary to the public interest.
2026-15458, Civil Money Penalty for Actions in Contempt of an Immigration Judge's Proper Exercise of Authority
This notice of proposed rulemaking ("NPRM") would implement a provision of the Immigration and Nationality Act ("INA" or "the Act") that authorizes Immigration Judges, under regulations prescribed by the Attorney General, to sanction by civil money penalty any action (or inaction) in contempt of the proper exercise of their authority by certain individuals. The rule would: define the scope of the contempt authority; provide procedures for contempt findings, penalty determinations, and penalty payment; establish an appellate process; and implement oversight of the use of contempt authority. The rule would also make conforming changes to the grounds for practitioner discipline.
2026-13586, Registering NFA Firearms That Fall Out of Government Contract
If you make special firearms for the U.S. Government and your contract ends, you’ll now have a new way to register those guns even if you missed the usual deadline. This change helps manufacturers avoid penalties and keeps everything clear and fair. Comments on this proposal are open until September 4, 2026, so don’t miss your chance to weigh in!
2026-11526, Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment
Starting July 9, 2026, new rules make it easier for doctors and pharmacies to provide medicine that helps people recover from opioid addiction. These changes affect healthcare providers by expanding who can give medication-assisted treatment and how pharmacies can deliver these medicines. The goal? Faster, safer access to treatment with clear rules that save time and support recovery.
2026-10128, Revision of Applications for Manufacturing and Procurement Quotas
The DEA wants to update how companies apply for permission to make and buy certain controlled drugs and chemicals. These changes will make the rules clearer, help prevent drug shortages, and ensure enough supply for medical and scientific needs. If you’re a manufacturer or involved in this process, get ready to follow new steps and share your thoughts by July 20, 2026.
2026-09160, Implementing PATRIOT Act Improvements: Contraband Cigarettes and Smokeless Tobacco
Starting June 8, 2026, new rules crack down harder on illegal cigarette and smokeless tobacco sales. The government lowered the amount that counts as smuggling from 60,000 to just 10,000 cigarettes and now includes smokeless tobacco in the crackdown. Sellers and distributors must keep better records and report more info, making it tougher to dodge the law and protect honest businesses.
Previous / Next Documents
Previous: 2026-19433, Agency Information Collection Activities; Proposed eCollection, eComments Requested; Extension Without Change of a Previously Approved Collection; Title-Application for Import Quota for Ephedrine, Pseudoephedrine, and Phenylpropanolamine (DEA Form 488)
The DEA is asking to keep using the same form (DEA Form 488) for people who want to import certain chemicals like Ephedrine and Pseudoephedrine next year. They’re not changing the form but want your feedback on how easy it is to use. If you import these chemicals, this affects you, and you have until November 23, 2026, to share your thoughts—no new fees or changes, just a smooth extension!
Next: 2026-19435, Agency Information Collection Activities; Proposed eCollection eComments Requested; Extension Without Change of a Previously Approved Collection; Title-Application for Individual Manufacturing Quota for a Basic Class of Controlled Substance and for Ephedrine, Pseudoephedrine, and Phenylpropanolamine (DEA Form 189)
The DEA is asking to keep using the same form (DEA Form 189) for companies to apply for permission to make certain controlled substances like ephedrine and pseudoephedrine. This is just a paperwork update with no changes to the form or fees, and they want your feedback by November 23, 2026. If you’re involved in making these substances, this keeps the process smooth and clear without extra costs or delays.